Delhi, India

Sunny Manohar

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Sunny Manohar

Introduction

Sunny Manohar is a notable inventor based in Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, his work focuses on developing compounds that address various medical conditions.

Latest Patents

One of Sunny Manohar's latest patents is titled "Aminoquinoline derivatives and uses thereof." This patent describes aminoquinoline and aminoacridine-based hybrids, along with pharmaceutical compositions and medicaments that incorporate these hybrids. The methods outlined in this patent are aimed at diagnosing and treating infections, neurodegenerative diseases, inflammation, and disorders treatable with dopamine agonists, such as restless leg syndrome. Another significant patent is "Curcumin analogs and methods of making and using thereof." This patent details compounds with specific formulas and the methods for their production and application.

Career Highlights

Sunny has worked with esteemed institutions, including the University of Delhi and The McLean Hospital Corporation. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of Sunny's notable coworkers include Diwan S Rawat and Ummadisetty Chinna Rajesh, who have also played important roles in advancing research in their respective areas.

Conclusion

Sunny Manohar's innovative work and patents reflect his commitment to improving healthcare through scientific advancements. His contributions are paving the way for new treatments and therapies in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…